MEDLINE Journals

    Quality of life measures in schizophrenia.

    Bobes J, García-Portilla P, Sáiz PA, et al. 
    Eur Psychiatry 2005 Oct.:S313-7.

    The recognition of the importance of evaluating the quality of life of patients with schizophrenia highlighted the importance of developing appropriate instruments. In this paper we review the available quality of life instruments focusing on their conceptual framework, structure, administration and psychometric properties. First, we address the generic instruments that have been validated for schizophrenic populations, namely the World Health Organization Quality of Life Assessment (WHOQOL), the Medical Outcome Study (MOS) 36-Item Short-Form Health Survey (SF-36) and the EuroQoL-5 Dimensions (EQ-5D). Then, we focus on instruments that have been specifically developed for patients with schizophrenia and other or severe mentally illness such as the Quality of Life Scale (QLS), the Quality of Life Interview (QoLI), the Lancashire Quality of Life Profile (LQoLP), the Sevilla Quality of Life Questionnaire (SQLQ), the Personal Evaluation of Transitions in Treatment (PETIT), and the Quality of Life Questionnaire in Schizophrenia (S-QoL).

    Health Status
    Quality of Life
    Schizophrenic Psychology


    Pub Type(s)
    Journal Article Review
    PubMed ID


    Content Manager
    Related Content

    Quality of life in schizophrenia measured by the MOS SF-36 and the Lancashire Quality of Life Profile: a comparison.

    Assessing health-related quality of life in patients suffering from schizophrenia: a comparison of instruments.

    Critical evaluation of the use of research tools in evaluating quality of life for people with schizophrenia.

    [Development and validation of a self rating quality of life scale: the S-QoL].

    A comparative review of generic quality-of-life instruments.

    Validity of the EQ-5D in assessing and valuing health status in patients with schizophrenic, schizotypal or delusional disorders.

    Not all roads lead to Rome-a review of quality of life measurement in adults with diabetes.

    The relationship between quality of life and clinical efficacy from a randomized trial comparing olanzapine and ziprasidone.